breast cancer |
37 |
chinese |
19 |
oncology |
18 |
cancer |
9 |
colorectal cancer |
9 |
brca2 |
8 |
advanced breast cancer |
7 |
brca1 |
7 |
medical sciences |
7 |
microrna |
7 |
ovarian cancer |
7 |
pten |
7 |
adult oncology |
6 |
biomarkers |
6 |
breast neoplasms |
6 |
female |
6 |
hepatectomy |
6 |
humans |
6 |
liver cancer |
6 |
mental health |
6 |
metastases |
6 |
pediatric cardiology |
6 |
perceived need |
6 |
supportive care |
6 |
supportive care needs |
6 |
survival |
6 |
ventricular function |
6 |
acupuncture |
5 |
asian continental ancestry group - genetics |
5 |
attention bias |
5 |
biomarker |
5 |
brca2 protein - genetics |
5 |
breast cancer risk |
5 |
chemobrain |
5 |
chemotherapy |
5 |
chronic distress |
5 |
circulating microrna |
5 |
cogntivie bias |
5 |
esophageal cancer susceptibility gene |
5 |
gastric cancer |
5 |
hereditary breast cancer |
5 |
implementation study |
5 |
interpretation bias |
5 |
loss‐of‐function mutations |
5 |
mild cognitive impairment |
5 |
mutation |
5 |
palb2 mutation |
5 |
psychological distress |
5 |
stepped-care model |
5 |
survivorship |
5 |
symptom distress screening |
5 |
symptom management |
5 |
synthetic lethality |
5 |
trigeminal nerve stimulation |
5 |
activity impairment |
4 |
akt |
4 |
anthracycline |
4 |
antibodies, monoclonal, humanized - pharmacology |
4 |
antineoplastic agents - pharmacology |
4 |
anxiety |
4 |
attentional bias |
4 |
autophagy |
4 |
avoidance |
4 |
brca-negative |
4 |
breast neoplasms - blood - diagnosis - genetics - pathology |
4 |
breast neoplasms - drug therapy - enzymology - genetics - pathology |
4 |
breast neoplasms - genetics - pathology |
4 |
colorectal neoplasms |
4 |
confirmatory factor analysis |
4 |
crc patients |
4 |
decisional conflict |
4 |
depression |
4 |
diagnostic marker |
4 |
dna methylation - genetics |
4 |
dna mutational analysis |
4 |
down-regulation - genetics |
4 |
drug resistance, neoplasm |
4 |
ductal carcinoma in situ |
4 |
employment |
4 |
ep4 |
4 |
erbb-2 |
4 |
fear of cancer recurrence |
4 |
fear of cancer recurrence trajectory |
4 |
genes, brca1 |
4 |
genes, brca2 |
4 |
her2-positive breast cancer |
4 |
hypermethylation |
4 |
intrusive thoughts |
4 |
killin |
4 |
membrane transport proteins - genetics |
4 |
metacognition |
4 |
metastatic disease |
4 |
methylation |
4 |
mir-92 |
4 |
mtor |
4 |
multigene panel |
4 |
neoadjuvant therapy |
4 |
neoplasm metastasis |
4 |
neuroticism |
4 |
nf-κb |
4 |
notch1 |
4 |
pathologic complete response |
4 |
patient satisfaction |
4 |
perceived needs |
4 |
pi3 kinase |
4 |
prospective studies |
4 |
psychometric assessement |
4 |
receptor, erbb-2 - antagonists & inhibitors - biosynthesis - genetics - metabolism |
4 |
recurrence |
4 |
return to work |
4 |
somatic mutations |
4 |
stomach neoplasms - blood - diagnosis - genetics - pathology |
4 |
survival analysis |
4 |
taxane |
4 |
tec |
4 |
thyroid cancer |
4 |
trajectory patterns |
4 |
trastuzumab |
4 |
unmet information needs |
4 |
validation |
4 |
work condition |
4 |
work productivity |
4 |
adjuvant chemotherapy |
3 |
aluscan sequencing |
3 |
animals |
3 |
asian |
3 |
atrial switch |
3 |
behavior change |
3 |
brain metastases |
3 |
brca |
3 |
brca mutation |
3 |
brca1 protein - genetics |
3 |
breast cancer surgery |
3 |
breast carcinoma |
3 |
breast neoplasm |
3 |
breast neoplasms - complications - diagnosis - surgery |
3 |
breast neoplasms - ethnology - genetics |
3 |
breast surgical consultation |
3 |
breast symptoms |
3 |
breast tumor |
3 |
cancer chemotherapy |
3 |
cancer classification |
3 |
cancer risk |
3 |
cancer staging |
3 |
carcinoma |
3 |
carcinoma - genetics - pathology |
3 |
carcinoma, lobular - complications - diagnosis - secondary - surgery |
3 |
cell cycle proteins - biosynthesis - genetics |
3 |
cell transformation, neoplastic - genetics |
3 |
chinese breast cancer |
3 |
chinese women |
3 |
chrysomya bezziana |
3 |
circulating cell-free mirna |
3 |
clonal evolution |
3 |
cns metastases |
3 |
cnv calling |
3 |
compound heterozygous mutations |
3 |
controlled study |
3 |
copy number variation |
3 |
decision aid |
3 |
diagnosis |
3 |
diagnostic imaging |
3 |
dietary change |
3 |
diptera |
3 |
dna repair - genetics |
3 |
dnmt3a |
3 |
european |
3 |
fanconi anemia |
3 |
founder effect |
3 |
genetic counseling |
3 |
genetic testing |
3 |
genetics |
3 |
health |
3 |
health service development |
3 |
hereditary breast and ovarian cancers |
3 |
interstitial loss of heterozygosity |
3 |
intraductal |
3 |
lapatinib |
3 |
large genmic rearrangements |
3 |
larva |
3 |
lymphatic metastasis |
3 |
machine learning |
3 |
mastectomy |
3 |
metastasis |
3 |
middle aged |
3 |
mir-143 |
3 |
mir-199a-5p |
3 |
mir-940 |
3 |
multiplex ligation-dependent probe amplification |
3 |
myiasis |
3 |
neratinib |
3 |
noninfiltrating |
3 |
obstetrics and gynecology |
3 |
oncology nutrition |
3 |
patient delay |
3 |
pilot-testing |
3 |
plasma |
3 |
precancer mutations |
3 |
psychosocial factors |
3 |
radiation |
3 |
screw worm infection - diagnosis - parasitology - surgery |
3 |
screwworm |
3 |
shared decision making |
3 |
single-nucleotide variation |
3 |
systemic ventricular function |
3 |
tetralogy of fallot |
3 |
tp53 mutation |
3 |
transposition of the great arteries |
3 |
treatment outcome |
3 |
triple-negative breast cancer |
3 |
tumor suppressor |
3 |
tyrosine kinase inhibitor |
3 |
variant of unknown significance |
3 |
vus |
3 |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (nnk) |
2 |
acetylcholine receptors |
2 |
adipogenesis |
2 |
air travel |
2 |
anaplastic large cell lymphoma |
2 |
angiosarcoma |
2 |
antineoplastic agents - therapeutic use |
2 |
asia |
2 |
atypical ductal hyperplasia |
2 |
axillary dissection |
2 |
axillary surgery |
2 |
blood sampling |
2 |
body mass index |
2 |
bone scintiscanning |
2 |
brca1 gene |
2 |
brca1/2 |
2 |
breast - cancer - genetic aspects. |
2 |
breast - cancer - patients - china - hong kong. |
2 |
breast and ovarian cancer |
2 |
breast cancer progression |
2 |
breast cancer survival analysis |
2 |
breast conservation |
2 |
breast implant |
2 |
breast neoplasms - drug therapy - pathology - surgery |
2 |
breast neoplasms - genetics |
2 |
breast neoplasms, male |
2 |
breast surgery |
2 |
breast-cancer |
2 |
cancer cell |
2 |
cancer development |
2 |
cancer gene therapy |
2 |
cancer hormone therapy |
2 |
cancer screening |
2 |
cancer survival |
2 |
case report |
2 |
cathelicidin antimicrobia |
2 |
china |
2 |
chinese population |
2 |
chromosome 5 |
2 |
cilengitide |
2 |
clinical features |
2 |
communicable diseases |
2 |
complementary dna |
2 |
core needle biopsy |
2 |
cost effective |
2 |
covid-19 |
2 |
de novo metastatic breast cancer |
2 |
de novo mutation |
2 |
deep-vein thrombosis |
2 |
down regulation |
2 |
early detection of cancer |
2 |
early onset |
2 |
epidemiology |
2 |
face masks |
2 |
false-negative rate |
2 |
fibroadenoma |
2 |
flight |
2 |
gene |
2 |
gene expression |
2 |
gene targeting |
2 |
genes section |
2 |
germline mutations |
2 |
glycolysis |
2 |
gpi |
2 |
haptoglobin |
2 |
healthcare survey |
2 |
hereditary breast |
2 |
hereditary breast and ovarian cancer syndrome |
2 |
high-intensity-focused ultrasound |
2 |
hong kong |
2 |
human |
2 |
incidence |
2 |
intraduct papilloma |
2 |
itgav |
2 |
learning curve |
2 |
local recurrence |
2 |
lymphatic mapping |
2 |
lymphedema |
2 |
lymphoedema |
2 |
mbc patients |
2 |
mendelian randomization |
2 |
messenger-rna decay |
2 |
micro rna |
2 |
mirn143 (alias) |
2 |
muscarinic receptors |
2 |
nicotinic receptors |
2 |
occupational health hazard |
2 |
ovarian |
2 |
ovarian cancer syndrome |
2 |
overtreatment |
2 |
pathology |
2 |
patient acceptance |
2 |
pediatric breast cancer |
2 |
penetrance |
2 |
pertuzumab |
2 |
phyllodes tumuor of breast |
2 |
poly(adp-ribose) polymerase inhibitors |
2 |
practice guideline |
2 |
prediction |
2 |
prevalence |
2 |
prognosis |
2 |
quality of life |
2 |
recql mutation |
2 |
references (27) view in table layout |
2 |
reoperation - statistics and numerical data |
2 |
retinoblastoma |
2 |
retractor |
2 |
review |
2 |
risk factor |
2 |
risk factors |
2 |
rna analysis |
2 |
sars-cov-2 |
2 |
scintigraphy |
2 |
secretory breast cancer |
2 |
segmental |
2 |
sentinel lymph node |
2 |
sentinel lymph node biopsy |
2 |
sentinel node mapping |
2 |
shift work |
2 |
smoking |
2 |
stomach cancer |
2 |
surgery |
2 |
surgical margin |
2 |
surgical technique |
2 |
surgical wound |
2 |
systematic review |
2 |
target therapy |
2 |
trial proposal |
2 |
triple negative breast cancer (tnbc) |
2 |
tumor associated macrophage |
2 |
tumor marker |
2 |
tumor microenvironment |
2 |
tumor-suppressor |
2 |
type 2 diabetes |
2 |
abdominal tissue |
1 |
acetaldehyde |
1 |
adjuvant |
1 |
adjuvant radiotherapy |
1 |
adjuvant therapy |
1 |
adjuvant treatment |
1 |
adolescent |
1 |
adult |
1 |
adverse outcome |
1 |
african ancestry |
1 |
age factors |
1 |
aged |
1 |
aged, 80 and over |
1 |
alanine aminotransferase blood level |
1 |
alcohol drinking |
1 |
aldehyde dehydrogenase‐2 |
1 |
ambulatory surgical procedures |
1 |
ambulatory surgical procedures - nursing |
1 |
anemia |
1 |
anesthesia |
1 |
anesthesia - nursing |
1 |
angiogenesis |
1 |
antibodies, monoclonal - administration and dosage |
1 |
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
1 |
apoptosis |
1 |
asian americans |
1 |
asian continental ancestry group |
1 |
asian continental ancestry group - psychology |
1 |
asian continental ancestry group - statistics and numerical data |
1 |
association |
1 |
autologous flap reconstruction |
1 |
bevacizumab |
1 |
binding site |
1 |
bioinformatics |
1 |
biopsy |
1 |
bipedicled abdominal flap |
1 |
brain metastasis |
1 |
brca gene |
1 |
brca1 and brca2 |
1 |
brca1/brca2 |
1 |
brca1/brca2 mutation carriers |
1 |
breast -- cancer -- china -- hong kong. |
1 |
breast -- cancer -- patients -- china -- hong kong. |
1 |
breast conservation therapy |
1 |
breast density |
1 |
breast imaging |
1 |
breast neoplasms - epidemiology |
1 |
breast neoplasms - epidemiology - genetics - metabolism |
1 |
breast neoplasms - epidemiology - pathology - therapy |
1 |
breast neoplasms - ethnology - pathology - therapy |
1 |
breast neoplasms - ethnology - psychology - surgery |
1 |
breast neoplasms - genetics - mortality - psychology - surgery |
1 |
breast neoplasms - genetics - prevention and control - surgery |
1 |
breast neoplasms - genetics - surgery |
1 |
breast neoplasms - metabolism - mortality |
1 |
breast neoplasms - pathology - radionuclide imaging - surgery |
1 |
breast neoplasms - pathology - surgery |
1 |
breast neoplasms - radiography |
1 |
breast neoplasms, male - genetics - prevention and control - surgery |
1 |
breast reconstruction |
1 |
breast screening |
1 |
breast size |
1 |
cancer detection rate |
1 |
cancer risks |
1 |
cancer-predisposition syndromes |
1 |
candidate gene studies |
1 |
carcinoma in situ - ethnology - psychology - surgery |
1 |
carcinoma, ductal, breast - ethnology - psychology - surgery |
1 |
carcinoma, intraductal, noninfiltrating - pathology - surgery |
1 |
case-control matching |
1 |
choice behavior |
1 |
chromatin |
1 |
chromosomes, human, pair 12 - genetics |
1 |
chromosomes, human, pair 19 - genetics |
1 |
chromosomes, human, pair 9 - genetics |
1 |
complex indel |
1 |
comprehensive geriatric assessment |
1 |
consortium |
1 |
corynebacterium |
1 |
cost-effectiveness |
1 |
counseling |
1 |
decision making |
1 |
diep flap |
1 |
disease-free survival |
1 |
ductoscopy |
1 |
early breast cancer |
1 |
early detection |
1 |
early-stage triple-negative breast cancer (etnbc) |
1 |
elderly |
1 |
estrogen receptors |
1 |
ethnicity |
1 |
european continental ancestry group - statistics and numerical data |
1 |
familial prostate cancer |
1 |
female surgeons |
1 |
fertility conservation |
1 |
first-line |
1 |
follow-up studies |
1 |
genetic counselling |
1 |
genetic screening |
1 |
genetic testing - utilization |
1 |
genetic variants |
1 |
genotype-phenotype correlations |
1 |
geography |
1 |
geriatric |
1 |
granuloma |
1 |
granulomatous lobular mastitis |
1 |
granulomatous mastitis |
1 |
health-related quality of life |
1 |
height |
1 |
her2 |
1 |
her2-oncogene |
1 |
her2-positive |
1 |
hereditary breast and ovarian cancer |
1 |
hereditary breast and ovarian cancer syndrome - genetics |
1 |
high-risk women |
1 |
histologic grade |
1 |
hodgkin disease - radiotherapy |
1 |
hodgkin's disease |
1 |
hong kong - epidemiology |
1 |
idiopathic granulomatous mastitis |
1 |
image processing |
1 |
implant reconstruction |
1 |
inherited cancer genetics |
1 |
international collaboration |
1 |
international consortium |
1 |
intraductal carcinoma |
1 |
invasive disease-free survival (idfs) |
1 |
japan |
1 |
ldsc regression |
1 |
lymph node dissection |
1 |
lymphatic metastasis - pathology - radionuclide imaging |
1 |
lymphocytic infiltration |
1 |
lymphoscintigraphy |
1 |
male breast cancer |
1 |
male surgeons |
1 |
mammographic density |
1 |
mammographic density assessment |
1 |
mammography |
1 |
mass screening - statistics and numerical data |
1 |
mastectomy - methods |
1 |
mastectomy - mortality |
1 |
mastectomy, segmental |
1 |
mastectomy, segmental - methods |
1 |
mastitis |
1 |
medicine & public health |
1 |
menarche |
1 |
metastatic breast cancer |
1 |
methods |
1 |
microdochectomy |
1 |
missense variants |
1 |
molecular subtypes |
1 |
morbidity |
1 |
mortality |
1 |
neoadjuvant chemotherapy |
1 |
neoadjuvant treatment |
1 |
neoplasm recurrence, local - drug therapy |
1 |
neoplasm recurrence, local - epidemiology |
1 |
neoplasm recurrence, local - prevention and control |
1 |
neoplasm staging |
1 |
neoplasm staging - methods |
1 |
neoplasms, radiation-induced - radiography |
1 |
neoplasms, second primary - radiography |
1 |
next-generation sequencing |
1 |
nipple discharge |
1 |
nodal marking |
1 |
occupational exposure - prevention & control - standards |
1 |
older chinese patients |
1 |
oophorectomy |
1 |
oral contraceptives |
1 |
ovarian neoplasms |
1 |
ovarian neoplasms - epidemiology - genetics - metabolism |
1 |
ovarian neoplasms - genetics |
1 |
ovarian neoplasms - genetics - prevention and control - surgery |
1 |
pathogenic sequence variant |
1 |
pathology, surgical - standards |
1 |
patient acceptance of health care - statistics and numerical data |
1 |
patient selection |
1 |
pembrolizumab |
1 |
pilot |
1 |
polymorphism, single nucleotide |
1 |
population surveillance |
1 |
postmastectomy |
1 |
pre-operative axillary ultrasound |
1 |
pregnancy |
1 |
preoperative care |
1 |
primary endocrine therapy |
1 |
primary prevention - statistics and numerical data |
1 |
prophylactic mastectomy |
1 |
prophylaxis |
1 |
prospective |
1 |
prostatic neoplasms |
1 |
prs |
1 |
psycho-oncology |
1 |
qualitative |
1 |
race/ethnicity |
1 |
radiation safety |
1 |
radiometry |
1 |
radiopharmaceuticals - diagnostic use |
1 |
re-evaluation |
1 |
receptor, erbb-2 - metabolism |
1 |
receptors, estrogen - metabolism |
1 |
receptors, progesterone - metabolism |
1 |
retrospective |
1 |
retrospective studies |
1 |
risk profiling |
1 |
risk-reducing surgery |
1 |
screening |
1 |
seer program |
1 |
sentinel lymph node (sln) |
1 |
sentinel lymph node biopsy - methods |
1 |
single nucleotide polymorphism |
1 |
snp |
1 |
snps |
1 |
southern chinese |
1 |
specimen handling - standards |
1 |
spect/ct |
1 |
subgroubs |
1 |
superparamagnetic iron oxide (spio) |
1 |
surgical oncology |
1 |
surveillance schemes |
1 |
survival outcome |
1 |
survival rate |
1 |
tamoxifen |
1 |
targeted axillary dissection |
1 |
telephone |
1 |
tertiary care centers |
1 |
thrombocytopenia |
1 |
tram flap |
1 |
transheterozygosity |
1 |
treatment |
1 |
unclassified variant |
1 |
variant calling |
1 |
whole-brain irradiation |
1 |
whole-genome sequencing |
1 |
women's health |
1 |
work-life balance |
1 |